Vertex (VRTX) at JPM Healthcare Conference on CF program and Phase 3 milestones… “And in 2021, we also achieved important risk-lowering milestones in progress in 3 other pipeline programs, VX-147 in APOL1-mediated kidney disease; VX-880 in type 1 dia...